Directa Plus Plc (AIM:DCTA)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 7.05M |
| Revenue (ttm) | 6.15M |
| Net Income (ttm) | -3.70M |
| Shares Out | 104.42M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 39,694 |
| Average Volume | 131,068 |
| Open | 7.00 |
| Previous Close | 6.75 |
| Day's Range | 6.60 - 7.00 |
| 52-Week Range | 5.00 - 24.00 |
| Beta | 1.43 |
| RSI | 35.03 |
| Earnings Date | Jun 10, 2026 |
About Directa Plus
Directa Plus Plc manufactures and sells graphene-based products for industrial and commercial applications in Italy, Romania, and internationally. The company operates through Textiles, Environmental Remediation, and Others segments. It also engages in the business of waste management and decontamination services, as well as provides textile membranes, including graphene-based technical and high-performance membranes. The company offers its products under the G+ brand name. Its products are used in environment, textile, composites, elastomers, ... [Read more]
Financial Performance
In 2024, Directa Plus's revenue was 6.66 million, a decrease of -36.74% compared to the previous year's 10.53 million. Losses were -5.14 million, 33.3% more than in 2023.
Financial numbers in EUR Financial StatementsNews
AIM Market Roundup: Ethernity, Goldstone, Quartix
Ethernity, Goldstone, Quartix are today's top risers, while Directa Plus, Union Jack Oil take the biggest fall on London's AIM market
Directa Plus Earnings Call Transcript: H1 2025
Revenue rose 15% and EBITDA loss narrowed 38% year-over-year in H1 2025, driven by production upgrades and cost controls. Major contracts in defense and environmental sectors, plus a strong recurring revenue base, support continued double-digit growth and near-term EBITDA breakeven.
Directa Plus Earnings Call Transcript: H2 2024
2024 saw revenue decline due to order delays and strategic exits, but operational restructuring, cost savings, and production upgrades position the company for recovery in 2025. Cash reserves are strong, and new contracts plus a growing IP portfolio support future growth.